Browse All

Current Filters

CLEAR FILTER x

TITLE

Title
    Author Last Name
      Session Name
        Topic
          Program Number
            Author Institution

              Association of Anti-inflammatory Therapy Use with the Incidence of Parkinson’s Disease: A Person-Time Analysis Among Patients with Autoimmune Diseases

              Author:Haas, Jennifer   Potashman, Michele   Pandit, Ambrish   Stafkey-Mailey, Dana   Coric, Vladimir   Singer, Wolfgang   L'Italien, Gilbert   

              Session Name:S2: Movement Disorders: Epidemiology and Clinical Aspects  

              Topic:Movement Disorders  

              Program Number:S2.003  

              Author Institution:Xcenda GmbH, Cencora Inc., Hannover, Germany  Biohaven Pharmaceuticals, Inc., New Haven, CT  Cencora Inc. , Conshohocken, PA  Mayo Clinic, Rochester, MN  

              Re-weighting MDS-UPDRS Motor Items for Optimal Sensitivity to Parkinson’s Disease Progression in Untreated Patients Using Parkinson’s Progression Markers Initiative Data

              Author:L'Italien, Gilbert   Dickson, Samuel   Rogula, Basia   Dubow, Jordan   Kozauer, Nick   Powell, Lauren   Potashman, Michele   Crimin, Kim   O'Keefe, Patrick   Korol, Ellen   Crabtree, Madeline   Nagase, Fernanda   Coric, Vladimir   Hendrix, Suzanne   

              Session Name:S2: Movement Disorders: Epidemiology and Clinical Aspects  

              Topic:Movement Disorders  

              Program Number:S2.004  

              Author Institution:Biohaven Pharmaceuticals, Inc., New Haven, CT  Pentara Corporation, Salt Lake City, UT  Broadstreet HEOR, Vancouver, BC, Canada  Clintrex, Sarasota, FL  Pentara Corporation, Millcreek, UT  

              Matching-adjusted Indirect Comparison of Troriluzole Versus Untreated Natural History Cohort in Spinocerebellar Ataxia

              Author:Beiner, Melissa   Powell, Lauren   Rogula, Basia   Potashman, Michele   Wirtz, Victoria   Schmahmann, Jeremy   Perlman, Susan   Coric, Vladimir   L'Italien, Gilbert   

              Session Name:S35: Movement Disorders: Hyperkinetic Movement Disorders  

              Topic:Movement Disorders  

              Program Number:S35.009  

              Author Institution:Biohaven Pharmaceuticals, Inc., New Haven, CT  Broadstreet HEOR, Vancouver, BC, Canada  Massachusettes General Hospital, Boston, MA  UCLA School of Medicine, Los Angeles, CA  

              Functional Impairments in Patients with KCNQ2-DEE: Associations Among Key Clinical Features

              Author:Berg, Anne   Lerner, Jason   Millichap, John   L'Italien, Gilbert   Coric, Vladimir   Potashman, Michele   

              Session Name:P1: Epilepsy/Clinical Neurophysiology (EEG): Pediatric Epilepsy 1  

              Topic:Epilepsy/Clinical Neurophysiology (EEG)  

              Program Number:P1.007  

              Author Institution:Northwestern Univesity Feinberg School of Medicine, Dekalb, IL  Biohaven Pharmaceuticals, Inc., New Haven, CT  Northwestern Univesity Feinberg School of Medicine, Chicago, IL  

              Automated Video-based Characterization of Movement Quality in a Phase III Clinical Trial of Troriluzole in Subjects with Spinocerebellar Ataxia

              Author:Beiner, Melissa   Oikonomou, Evangelos   L'Italien, Gilbert   Khera, Rohan   Potashman, Michele   Schmahmann, Jeremy   Perlman, Susan   Coric, Vladimir   

              Session Name:P6: Movement Disorders: Ataxias 1  

              Topic:Movement Disorders  

              Program Number:P6.014  

              Author Institution:Biohaven Pharmaceuticals, Inc., New Haven, CT  Yale School of Medicine, New Haven, CT  Massachusettes General Hospital, Boston, MA  UCLA School of Medicine, Los Angeles, CA